• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Applied Therapeutics

News headline image
Applied Therapeutics Shares Letter to Stockholders Recommending Tender of Shares Following Offer Expiration Extension
January 29, 2026
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Cycle Pharmaceuticals to Acquire Applied Therapeutics
December 11, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Announces Corporate Updates
November 20, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports Third Quarter 2025 Financial Results
November 13, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Provides Update Following Meeting with FDA
September 29, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports Second Quarter 2025 Financial Results
August 13, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Announces Key Leadership Appointments
June 17, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 18, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports First Quarter 2025 Financial Results
May 13, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 09, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
April 14, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
March 31, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
March 19, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality
January 21, 2025
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Appoints John H. Johnson as Executive Chairman
December 20, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT RVPH VSTM
News headline image
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia
November 27, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports Third Quarter 2024 Financial Results
November 07, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
November 05, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
September 18, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics to Participate in Upcoming Investor Conferences
September 04, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports Second Quarter 2024 Financial Results
August 07, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Added to Russell 3000® Index
July 01, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports First Quarter 2024 Financial Results
May 09, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 07, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
April 15, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
April 04, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Provides FDA Update on PDUFA Target Action Date for Govorestat for the Treatment of Classic Galactosemia
March 28, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Reports Fourth Quarter and Year-end 2023 Financial Results
March 06, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Announces $100 Million Private Placement
February 28, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
News headline image
Applied Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Govorestat for the Treatment of Classic Galactosemia
February 28, 2024
From Applied Therapeutics
Via GlobeNewswire
Tickers APLT
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap